Gevo Vs. Novo Nordisk AS Industry Stock Comparison

Sell

36

GEVO
Gevo

Last Price:

$1.52

Seasonality Move:

11.84%

Sell

13

NONOF
Novo Nordisk AS

Last Price:

$84.75

Seasonality Move:

6.94%

Sell

36

Gevo (GEVO) is a Sell

Is Gevo a Buy, Sell or Hold?

The current Gevo [GEVO] share price is $1.52. The Score for GEVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
GEVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

13

Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GEVO Stock Price Chart

What is Gevo's stock price today?

The Gevo share price today is $1.52

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GEVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

The Novo Nordisk AS share price today is $84.75

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

GEVO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	45.86	Sell
Chaikin Money Flow:	2184111	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.44 - 1.6)	Sell
Bollinger Bands (100):	(0.8 - 2.12)	Buy

NONOF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.51	Sell
Relative Strength Index (14 RSI):	24.55	Sell
Chaikin Money Flow:	64911	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(100.57 - 111.43)	Sell
Bollinger Bands (100):	(107.18 - 131.16)	Sell

GEVO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.52	Sell
20-day SMA:	1.55	Sell
50-day SMA:	1.9	Sell
200-day SMA:	1.06	Buy
8-day EMA:	1.51	Buy
20-day EMA:	1.56	Sell
50-day EMA:	1.63	Sell
200-day EMA:	1.31	Buy

NONOF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	105.03	Sell
20-day SMA:	106.85	Sell
50-day SMA:	109.33	Sell
200-day SMA:	126.14	Sell
8-day EMA:	102.09	Sell
20-day EMA:	105.65	Sell
50-day EMA:	110.06	Sell
200-day EMA:	118.01	Sell

Gevo Earnings Growth & GEVO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.01 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Gevo Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):